Empresa Kuros Biosciences AG Swiss Exchange
Acciones
CH0325814116
Biotecnología e investigación médica
Resumen de negocios
Ventas por actividad
CHF en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Medical Devices
100,0
%
| 13 | 73,8 % | 34 | 100,0 % | +153,03 % |
Ventas por región
CHF en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
97,8
%
| 17 | 96,6 % | 33 | 97,8 % | +88,93 % |
European Union
1,7
%
| 0 | 2,4 % | 1 | 1,7 % | +35,20 % |
Other
0,4
%
| 0 | 1,0 % | 0 | 0,4 % | -17,82 % |
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Joost de Bruijn
FOU | Founder | 58 | 04/12/17 |
Christopher Fair
CEO | Chief Executive Officer | 54 | 19/04/21 |
Daniel Geiger
DFI | Director of Finance/CFO | - | 17/02/23 |
Chief Tech/Sci/R&D Officer | - | 01/01/17 | |
Sjoerd Musters
COO | Chief Operating Officer | - | 01/10/22 |
Luuk van Dijk
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/15 |
Katherine Sage
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/21 |
John Griffin
PRN | Corporate Officer/Principal | - | 12/10/23 |
Marcel Borger
LAW | General Counsel | - | 01/01/20 |
Philippe Saudan
PRN | Corporate Officer/Principal | 57 | 10/08/16 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Scott P. Bruder
BRD | Director/Board Member | 62 | 14/06/18 |
Christopher Fair
CEO | Chief Executive Officer | 54 | 19/04/21 |
Joost de Bruijn
FOU | Founder | 58 | 04/12/17 |
Chairman | 67 | 23/05/17 | |
Oliver Walker
BRD | Director/Board Member | 55 | 14/06/18 |
Leanna Caron
BRD | Director/Board Member | 56 | 16/06/16 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 36 866 049 | 23 857 779 ( 64,71 %) | 17 244 ( 0,0468 %) | 64,71 % |
Participaciones
Nombre | Acciones | % | Valoración |
---|---|---|---|
KUROS BIOSCIENCES AG 3.15% | 1 160 106 | 3.15% | 7 805 309 $ |
Información de la empresa
Sector
Ventas por actividad
Ventas por región
Varia. 1 de ene. | Capi. | |
---|---|---|
-2,63 % | 102 mil M | |
+1,62 % | 96,29 mil M | |
+2,59 % | 22,18 mil M | |
-16,67 % | 21,2 mil M | |
-8,96 % | 18,31 mil M | |
-38,74 % | 17,38 mil M | |
-13,21 % | 16,36 mil M | |
+5,41 % | 13,97 mil M | |
+33,57 % | 12,17 mil M |